A time series of 110 patients with acute myocardial infarction admitted between January 1992 and June 1997 examined the effects of a clinical pathway. The pathway reduced length of hospital stay by 2.2 days and hospital charges by $1,008 without compro mising care quality and outcomes.
Get full access to this article
View all access options for this article.
References
1.
Gunnar RM, Bowdillon Pdv, Dixon DW, et al: Guidelines for the early management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). J Am Coll Cardiol16:249-252, 1990.
2.
Meehan TP, Hennen J., Radford MJ, et al: Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut. A quality improvement demonstration project. Ann Intern Med122:928-936, 1995.
3.
Brand DA, Newcomer LN, Freiburger A., et al: Cardiologists practices compared with practice guidelines. Use of beta-blockade after acute myocardial infarction. J Am Coll Cardiol26:1432-1436, 1995.
4.
Marciniak TA , Ellerbeck EF, Radford MJ, et al: Improving the quality of care for Medicare patients with acute myocardial infarction. Results from the cooperative cardiovascular project. JAMA279:1351-1357, 1998.
5.
O'Connor GT, Quinton HB, Traven ND, et al: Geographic variation in the treatment of acute myocardial infarction . The Cooperative Cardiovascular Project. JAMA281:627-633, 1999.
6.
Pearson SD, Goulart-Fisher D., Lee TH: Critical pathways as a strategy for improving care: Problems and potential . Ann Intern Med123:941-948, 1995.
7.
Kegel LM: Case management, critical pathways, and myocardial infarction. Crit Care Nurse16:97-112, 1996.
8.
Nichol G., Walls R., Goldman L., et al: A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: Recommendations and potential impact. Ann Intern Med127:996-1005, 1997.
9.
Zalenski RJ, McCarren M., Roberts R., et al: An evaluation of a chest pain diagnostic protocol to exclude acute cardiac ischemia in the Emergency Department. Arch Intern Med157:1085-1091, 1997.
10.
Cannon CP, Antman EM, Walls R., et al: Time as an adjunctive agent to thrombolytic therapy. J Thromb Thrombolysis1:27-34, 1994.
11.
Kulick DL, Rahimtoola SH: Risk stratification in survivors of acute myocardial infarction: Routine cardiac catheterization and angiography is a reasonable approach in most patients . Am Heart J121:641-656, 1991.
12.
The TIMI IIIB Investigators: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction: Results of the TIMI IIIB trial. Circulation89:1545-1556, 1994.
13.
Ryan TJ, Anderson JL, Antman EM, et al: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol28:1328-1342, 1996.
14.
Boden WE, O'Rourke RA, Crawford MH, et al: Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy.Veterans Affairs Non-Q Wave Infarctions Strategies in Hospital (VANQWISH) Trial Investigators .N Engl J Med338:1785-1792, 1998.
15.
Ellrodt AG, Conner L., Riedinger M., et al: Measuring and improving physician compliance with clinical practice guidelines. A controlled interventional trial. Ann Intern Med122:277-282, 1995.
16.
Newby LK, Califf RM, Guerci A., et al: Early discharge in the thrombolytic era: An analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol27:625-632, 1996.
17.
Reeder GS, Bailey KR, Gersh BJ, et al, for the Mayo Coronary Care Unit and Catheterization Laboratory Groups: Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: A randomized prospective trial. Mayo Clin Proc69:5-12, 1994.
18.
Barbagelata A., Granger CB, Topol EJ, et al, for the TAMI Study Group: Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. Am J Cardiol76:1007-1013, 1995.
19.
Jollis JG, DeLong ER, Peterson ED, et al: Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med335:1880-1887, 1996.
20.
Sanz G., Betriu A., Oller G., et al: Feasibility of early discharge after acute Q wave myocardial infarction in patients not receiving thrombolytic treatment. J Am Coll Cardiol22:1795-1801, 1993 .
21.
Wilkinson P. , Stevenson R., Ranjadayalan K., et al: Early discharge after acute myocardial infarction: Risks and benefits. Br Heart J74:71-75, 1995.
22.
Grines CL, Marsalese DL, Brodie B., et al: Safety and cost-effectiveness of early discharge after primary angioplasty in low-risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol31:967-972, 1998.
